Ideaya Biosciences Inc (IDYA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.94B
Last updated: Nov 17, 2026 at 4:33 PM ET
Ideaya Biosciences Inc (IDYA) Stock Chart
Ideaya Biosciences (IDYA) has a latest price of $27.40 on Nov 17, 2026, 35.8% below its 52-week high of $42.68. Its price fell 14.7% over the past 12 months. The month-end price rose 49.1% over the 5 years through Oct 2026, a compound annual rate of 8.3%.
Price Chart
From May 2019 to Oct 2026, its highest month-end close was $44.70 in Feb 2024 and its lowest $4.12 in Mar 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IDYA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IDYA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 29.5%, and over 6 months it fell 3.2%. The month-end price rose 17.6% over the 3 years through Oct 2026, a compound annual rate of 5.6%.
| Period | Change |
|---|---|
| 1 month | -19.0% |
| 3 months | -29.5% |
| 6 months | -3.2% |
| 12 months | -14.7% |
| 12 months, with dividends | -14.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +17.6% | +5.6% |
| 5 years | +49.1% | +8.3% |
Price by Year
Its best calendar year was 2023, when the price rose 95.8%, and its weakest was 2024, when it fell 27.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $31.96 | -7.5% |
| 2025 | $34.57 | +34.5% |
| 2024 | $25.70 | -27.8% |
| 2023 | $35.58 | +95.8% |
| 2022 | $18.17 | -23.1% |
| 2021 | $23.64 | +68.9% |
| 2020 | $14.00 | +86.7% |
Trading Range
The price is 21.8% below its 50-day average of $35.05 and 19.0% below its 200-day average of $33.81.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $27.40 | |
| 52-week high | $42.68 | -35.8% |
| 52-week low | $26.81 | +2.2% |
| 50-day average | $35.05 | -21.8% |
| 200-day average | $33.81 | -19.0% |
Price Risk
Over 3 years, its largest fall from a peak was 69.2%.
| Measure | Value |
|---|---|
| 1-year beta | 1.06 |
| Largest fall, 1 year | -35.5% |
| Largest fall, 3 years | -69.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IDYA
What is IDYA's 1-year price change?
Ideaya Biosciences's price fell 14.7% over the past 12 months. With dividends included, the 12-month total return was -14.7%.
What is IDYA's 5-year price change?
Ideaya Biosciences's month-end price rose 49.1% over the 5 years through Oct 2026, a compound annual rate of 8.3%. These figures leave out dividends.
What is IDYA's 52-week high and low?
Ideaya Biosciences's 52-week high is $42.68 and its 52-week low is $26.81. Its latest price of $27.40 on Nov 17, 2026 is 35.8% below the high.
What is IDYA's beta?
Ideaya Biosciences's 1-year beta against the S&P 500 is 1.06, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 35.5%.
Is the IDYA chart free?
Yes. Advanced Charting for IDYA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IDYA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors